CONTROLLED TRIAL OF PERGOLIDE MESYLATE IN PARKINSONS-DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY

被引:31
作者
JANKOVIC, J
机构
关键词
D O I
10.1212/WNL.33.4.505
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:505 / 507
页数:3
相关论文
共 15 条
[1]   DOPAMINE-RECEPTORS EXPLAINED [J].
CREESE, I .
TRENDS IN NEUROSCIENCES, 1982, 5 (02) :40-43
[2]  
DUVOISIN RC, 1981, NEUROLOGY NY, V31, pA133
[3]   INTERACTION OF PERGOLIDE WITH CENTRAL DOPAMINERGIC RECEPTORS [J].
GOLDSTEIN, M ;
LIEBERMAN, A ;
LEW, JY ;
ASANO, T ;
ROSENFELD, MR ;
MAKMAN, MH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06) :3725-3728
[4]  
GOLDSTEIN M, 1979, DOPAMINERGIC ERGOT D, P253
[5]   PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].
HOEHN, MM ;
YAHR, MD .
NEUROLOGY, 1967, 17 (05) :427-&
[6]  
JACKSON JA, ANN NEUROL
[7]   QUANTITATIVE ASSESSMENT OF PARKINSONIAN AND ESSENTIAL TREMOR - CLINICAL-APPLICATION OF TRIAXIAL ACCELEROMETRY [J].
JANKOVIC, J ;
FROST, JD .
NEUROLOGY, 1981, 31 (10) :1235-1240
[8]  
JANKOVIC J, 1981, ANN NEUROL, V10, P64
[9]  
JANKOVIC J, 1982, CLIN NEUROPHARMACOL, V5, P519
[10]  
KLAWANS HL, 1979, ANN NEUROL, V6, pA157